Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease

Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease

The outbreak of SARS-CoV-2 developed into a global pandemic affecting millions of people worldwide. Despite one year of intensive research, the current treatment options for SARS-CoV-2 infected people are still limited. Clearly, novel antiviral compounds for the treatment of SARS-CoV-2 infected pati...

Full description

Bibliographic Details
Main Authors: Lukas van de Sand, Maren Bormann, Mira Alt, Leonie Schipper, Christiane Silke Heilingloh, Eike Steinmann, Daniel Todt, Ulf Dittmer, Carina Elsner, Oliver Witzke, Adalbert Krawczyk
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Viruses
Subjects:
SARS-CoV-2
glycyrrhizin
main protease
Online Access:https://www.mdpi.com/1999-4915/13/4/609

Internet

https://www.mdpi.com/1999-4915/13/4/609

Similar Items